Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, January 5, 2015

Israel's BrainStorm says stem cell drug benefits most patients in ALS trial

Israel's BrainStorm Cell Therapeutics said final results from a clinical trial of its adult stem cell treatment in amyotrophic lateral sclerosis were positive, with most patients showing a slowing in the disease's progression. According to the ALS Association, 5,600 people in the United States are diagnosed each year with the neurodegenerative disease, which has severely disabled British physicist Stephen Hawking.

http://ift.tt/1Fa2GlN

No comments:

Post a Comment

Popular Stem Cell Roundup Posts